• Anil Pokhrel, Anubhav Sharma, Dikshya Khatiwada, Jagdish Lamsal, and Laxman Adhikary.
• Department of Nephrology, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal.
• JNMA J Nepal Med Assoc. 2023 Mar 1; 61 (259): 224227224-227.

IntroductionAdministration of an intravenous contrast medium, which is used in various routine hospital procedures, can lead to the development of nephropathy in some patients. This contrast-induced nephropathy is one of the most common reasons for hospital-acquired acute kidney injury. This study aimed to find out the prevalence of contrast-induced nephropathy among patients administered with contrast material at a tertiary care centre.MethodsThis descriptive cross-sectional study was conducted from 4 March 2022 to 23 May 2022 at a tertiary care centre after taking ethical approval from the Institutional Review Committee (Reference number: 0812202106). Patients administered with an intravenous contrast medium for diagnostic imaging were included in the study. Data including sociodemographic variables and renal function test results were collected. A convenience sampling method was used. Point estimate was done and 95% Confidence Interval was calculated.ResultsAmong 174 participants, contrast-induced nephropathy was found in 86 (48.31%) (48.24-48.39, 95% Confidence Interval).ConclusionsThe study showed that the prevalence of contrast-induced nephropathy was higher than findings from other studies done in a similar setting.Keywordscontrast material; kidney disease; prevalence.

18 keywords...

hide…